1.河北中医药大学研究生院,河北省石家庄市桥西区新石南路326号,050091
2.河北省中医院
3.河北省浊毒证重点实验室
4.中国中医科学院望京医院
libolin0313@163.com
收稿:2024-04-22,
修回:2024-07-15,
纸质出版:2025-02-02
移动端阅览
范诗苑,杨倩,李佃贵等.基于浊毒理论分型论治便秘型肠易激综合征[J].中医杂志,2025,66(03):300-303.
FAN Shiyuan,YANG Qian,LI Diangui,et al.Pattern Identification and Treatment of Constipation-Predominant Irritable Bowel Syndrome Based on the Turbidity Toxin Theory[J].Journal of Traditional Chinese Medicine,2025,66(03):300-303.
范诗苑,杨倩,李佃贵等.基于浊毒理论分型论治便秘型肠易激综合征[J].中医杂志,2025,66(03):300-303. DOI: 10.13288/j.11-2166/r.2025.03.014.
FAN Shiyuan,YANG Qian,LI Diangui,et al.Pattern Identification and Treatment of Constipation-Predominant Irritable Bowel Syndrome Based on the Turbidity Toxin Theory[J].Journal of Traditional Chinese Medicine,2025,66(03):300-303. DOI: 10.13288/j.11-2166/r.2025.03.014.
以浊毒理论为指导,认为浊毒壅滞致肠腑通降失常是便秘型肠易激综合征的关键病机,治疗以化浊毒、通肠腑为基本治则。临证分为浊毒蕴热、浊毒兼肝郁气滞、浊毒兼气阴两虚三种证型,分别运用自拟通腑降浊方清热通腑、泄浊解毒,自拟疏肝降浊方疏肝行气、降浊解毒,自拟麻枳降浊方益气滋阴、润肠化浊解毒。
Guided by the turbidity toxin theory, it is believed that the key pathogenesis of constipation-predominant irritable bowel syndrome is the obstruction of turbidity toxin and the disruption of intestinal function. Treatment is based on the principles of dispelling turbidity toxin and promoting intestinal function. The clinical patterns can be divided into three types, turbidity toxin heat accumulation pattern, turbidity toxin combined with liver depression and
qi
stagnation pattern, and turbidity toxin combined with
qi
and
yin
deficiency pattern. The treatment can respectively use self-prescribed
Tongfu Jiangzhuo Formula
(通腑降浊方) to clear heat and unblock the bowels, direct the turbid downward and resolve toxins; use self-prescribed
Shugan Jiangzhuo Formula
(疏肝降浊方) to soothe the liver and move
qi
, direct the turbid downward and resolve toxins; use self-prescribed
Mazhi Jiangzhuo Formula
(麻枳降浊方) to boost
qi
and nourish
yin
, moisten the intestines to remove turbidity and resolve toxins.
OKA P , PARR H , BARBERIO B , et al . Global prevalence of irritable bowel syndrome according to Rome Ⅲor Ⅳcriteria:a systematic review and meta-analysis [J]. Lancet Gastroenterol Hepatol , 2020 , 5 ( 10 ): 908 - 917 .
中华中医药学会脾胃病分会 . 肠易激综合征中医诊疗专家共识意见(2017) [J]. 中医杂志 , 2017 , 58 ( 18 ): 1614 - 1620 .
HU Z , LI M , YAO L , et al . The level and prevalence of depression and anxiety among patients with different subtypes of irritable bowel syndrome: a network meta-analysis [J]. BMC Gastroenterol , 2021 , 21 ( 1 ): 23 .
赵娟娟 , 陆敏 . 便秘型肠易激综合征的中西医结合治疗进展 [J]. 广西中医药 , 2022 , 45 ( 2 ): 68 - 70 .
曹子涵 , 曹志群 . 便秘型肠易激综合征的中医治疗进展 [J]. 中医药通报 , 2023 , 22 ( 3 ): 69 - 72 .
李佃贵 . 从浊毒理论的建立与应用谈中医学创新与发展 [J]. 中医杂志 , 2020 , 61 ( 22 ): 1938 - 1940 .
唐旭东 , 卞立群 . 脾胃“通降理论”及其应用:脾胃学说传承与应用专题系列(3) [J]. 中医杂志 , 2012 , 53 ( 14 ): 1171 - 1173,1181 .
孙建慧 , 杨倩 , 刘阳 , 等 . 构建中医浊毒理论体系框架的思考 [J]. 中医杂志 , 2020 , 61 ( 8 ): 660 - 663 .
赵先平 , 肖新云 , 蔡锐 , 等 . 便秘相关肠道微生物研究进展 [J]. 中国微生态学杂志 , 2014 , 26 ( 10 ): 1236 - 1241 .
赵雯红 , 肖颖 , 王文举 , 等 . 以人体微生态学诠释浊毒理论的内涵 [J]. 中医杂志 , 2018 , 59 ( 3 ): 185 - 190 .
HOLTMANN GJ , FORD AC , TALLEY NJ . Pathophysio-logy of irritable bowel syndrome [J]. Lancet Gastroenterol Hepatol , 2016 , 1 ( 2 ): 133 - 146 .
杨倩 , 王小天 , 杜姚 , 等 . 麻枳降浊方改善便秘型肠易激综合征胃肠功能的疗效观察 [J]. 辽宁中医杂志 , 2015 , 42 ( 8 ): 1458 - 1460 .
杨倩 , 杜姚 , 郭子敬 , 等 . 麻枳降浊方对便秘型肠易激综合征大鼠肠道间质细胞的影响 [J]. 中医杂志 , 2015 , 56 ( 12 ): 1058 - 1060 .
杨倩 , 郭子敬 , 王小天 , 等 . 麻枳降浊方改善便秘型肠易激综合征模型大鼠肠组织中肥大细胞的实验研究 [J]. 辽宁中医杂志 , 2015 , 42 ( 7 ): 1360 - 1361 .
0
浏览量
0
下载量
1
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010102007558号